Finland· FI-REL-REL20626
Teveten Comp
A eprosartan und diuretika product containing eprosartan mesylate + hydrochlorothiazide, registered in Finland by Viatris Oy. The same ATC class is registered in 5 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Eprosartan und diuretika is registered in 5 of 19 countries.
Countries holding a registration under ATC C09DA02 (eprosartan und diuretika), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 3 of them publish a price we can compare per daily dose
Eprosartan und diuretika · ATC C09DA02
5 / 19 countries
- Belgiumprice
- Finlandprice
- Ireland
- Netherlands
- Norwayprice
The record
At a glance
Fimea (Finland)- Active substance
- Eprosartan mesylate + Hydrochlorothiazide
- Manufacturer
- Viatris Oy
- Country
- Finland (FI)
- ATC code
- C09DA02
- ATC class
- Eprosartan und Diuretika
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
80 interactions on record for eprosartan und diuretika.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Eprosartan und diuretika · interactions on record
80 records
80 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Eprosartan und diuretika in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainFUTURAN PLUS 600 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULAViatris Healthcare Limited
- GermanyEprosartan Comp. RatiopharmRatiopharm Gmbh
- IrelandTeveten Plus 600 mg/12.5 mg film-coated tabletsPCO Manufacturing Ltd.
- NorwayTeveten CompViatris Healthcare Ltd.
- SwedenTeveten Comp 600 mg/12,5 mg Filmdragerad tablettViatris AB
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Austria · Teveten Plus
- Belgium · Teveten Plus
- Germany · Eprosartan Comp. Ratiopharm, Teveten Plus Hct
- Spain · Futuran Plus, Navixen Plus
- Greece · Teveten Plus
- Ireland · Teveten Plus
- Luxembourg · Teveten Plus
- Netherlands · Teveten Plus
- Norway · Teveten Comp
- Portugal · Teveten Plus
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e0daebb0-64e9-4007-b59b-16beddb9a0e4 GET /v1/drugs/e0daebb0-64e9-4007-b59b-16beddb9a0e4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "1",
"form": "tabletti, kalvopäällysteinen",
"route": "Suun kautta",
"ddd_unit": "ED",
"strength": "600 mg / 12.5 mg",
"atc_label": "eprosartaani ja diureetit",
"ma_number": "19072",
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": null,
"fimea_rel_id": "REL20626",
"authorised_at": "2004-11-10"
}See everything about eprosartan und diuretika.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.